Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19 ... which could lead to treatments for the cognitive symptoms of Parkinson's ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...

The symptoms of alcohol-related dementia can vary, but they usually involve changes in how a person thinks and acts. Some ...

Axsome Therapeutics said on Monday its experimental treatment for the Alzheimer's disease-related agitation met the main goal of a late-stage trial.

According to Phipps, the drugs currently available to treat Alzheimer’s have only eased the symptoms rather than stop its ...